\
&
Contact us
Published on | 7 years ago
ProgrammesThe European Commission has posted the details about the amount of proposals submitted for the following call topics:
H2020-LC-SC3-2018-2019-2020:
Building a Low-Carbon, Climate Resilient Future: Secure, Clean and Efficient Energy
LC-SC3-RES-1–2019-2020: 23 proposals
LC-SC3-RES-14–2019: 13 proposals
H2020-LC-BAT-2019-2020:
Building a Low-Carbon, Climate Resilient Future: Next-Generation Batteries
LC-BAT-1-2019: 14 proposals
LC-BAT-2-2019: 27 proposals
LC-BAT-3-2019: 5 proposals
LC-BAT-4-2019: 15 proposals
LC-BAT-5-2019: 11 proposals
LC-BAT-6-2019: 8 proposals
LC-BAT-7-2019: 2 proposals
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.